| Patent application number | Description | Published |
|---|
| 20100168195 | DERIVATIVES AND ANALOGS OF CHROMAN AS FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS - In its many embodiments, the present invention provides a novel class of chroman compounds of formula I as α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of prepaxing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions. | 07-01-2010 |
| 20100197562 | FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS - In its many embodiments, the present invention provides a novel class of biaryl compounds as inhibitors of ÿ2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the ÿ2C adrenergic receptors using such compounds or pharmaceutical compositions. | 08-05-2010 |
| 20110060006 | Functionally Selective Alpha2C Adrenoreceptor Agonists - In its many embodiments, the present invention provides a novel class of heterocyclic derivatives as a2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the a2C adrenergic receptors using such compounds or pharmaceutical compositions. | 03-10-2011 |
| 20110130385 | Bicyclic Heterocylic Derivatives and Methods of Use - The present invention relates to novel bicyclic heterocycle derivatives, pharmaceutical compositions comprising the bicyclic heterocycle derivatives and the use of these compounds for treating or preventing allergy, an allergy-induced airway response, congestion, a cardiovascular disease, an inflammatory disease, a gastrointestinal disorder, a neurological disorder, a metabolic disorder, obesity or an obesity-related disorder, diabetes, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. R | 06-02-2011 |
| 20110136790 | Tricyclic Heterocyclic Derivatives and Methods of Use - The present invention relates to novel Tricyclic Heterocycle Derivatives, pharmaceutical compositions comprising the Tricyclic Heterocycle Derivatives and the use of these compounds for treating or preventing allergy, an allergy-induced airway response, congestion, a cardiovascular disease, an inflammatory disease, a gastrointestinal disorder, a neurological disorder, a metabolic disorder, obesity or an obesity-related disorder, diabetes, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. R1 is formula (Ia), (Ib) or (Ic); R | 06-09-2011 |
| 20110166124 | TRICYCLIC SPIROCYCLE DERIVATIVES AND METHODS OF USE - The present invention relates to novel Tricyclic Spirocycle Derivatives, pharmaceutical compositions comprising the Tricyclic Spirocycle Derivatives and the use of these compounds for treating or preventing allergy, an allergy-induced airway response, congestion, a cardiovascular disease, an inflammatory disease, a gastrointestinal disorder, a neurological disorder, a metabolic disorder, obesity or an obesity-related disorder, diabetes, a diabetic complication, impaired glucose tolerance or aired fasting glucose. | 07-07-2011 |
| 20110251207 | BIARYL-SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA 2C ADRENERGIC RECEPTOR MODULATORS - In its many embodiments, the present invention provides a novel class of biaryi spiroaminooxazoline analogues as modulators of α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions. | 10-13-2011 |
| 20130045914 | BIARYL SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA2C ADRENERGIC RECEPTOR MODULATORS - In its many embodiments, the present invention provides a novel class of biaryl spiroaminooxazoline analogues as modulators of α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions. | 02-21-2013 |
| 20130225582 | BIARYL-SPIROAMINOOXZAOLINE ANALOGUES AS ALPHA 2C ADRENERGIC RECEPTOR MODULATORS - In its many embodiments, the present invention provides a novel class of biaryl spiroaminooxazoline analogues as modulators of α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions. | 08-29-2013 |
| 20150361098 | HETEROBICYCLO-SUBSTITUTED [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES - Disclosed are compounds of Formula G1 (structurally represented): where “RG3” “Rd1” to “Rd4”, “n”, “m”, “p”, “W”, “X”, “Y”, and “Z” are defined herein which compounds are antagonists of A2A receptor. Disclosed herein also are uses of the compounds described herein as antagonists of the A2a receptor in the potential treatment or prevention of neurological disorders and diseases in which A2A receptors are involved. Disclosed herein also are pharmaceutical compositions comprising these compounds and uses of these pharmaceutical compositions. | 12-17-2015 |
| Patent application number | Description | Published |
|---|
| 20110151029 | Paxillin Stimulating Compositions and Cosmetic Uses Thereof - Cosmetic compositions comprising one or more paxillin stimulators and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The paxillin stimulators and combinations thereof are believed to have modulatory activity against at least one biochemical pathway implicated in skin aging. | 06-23-2011 |
| 20120003332 | Compositions and Methods for Stimulation MAGP-1 to Improve the Appearance of Skin - The present disclosure relates to methods for treating, preventing and improving the condition and aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, by application of one or a combination of natural compounds or extracts that stimulate MAGP-1 expression and which improves the appearance of aged and/or photodamaged skin. The compositions of the invention are topically applied to the skin, or are delivered by directed means to a site in need thereof in an amount effective to improve the condition and aesthetic appearance of skin. | 01-05-2012 |
| 20120004302 | Cosmetic Use of N-Substituted Sulfonyloxybenzylamines and Related Compounds - Cosmetic compositions comprising N-substituted sulfonyloxybenzylamines and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The N-substituted sulfonyloxybenzylamines are believed to have modulatory activity against one or more biochemical pathways implicated in skin aging. | 01-05-2012 |
| 20120171133 | Modulation of Dynein in Skin - Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents that modulate dynein expression in the skin. Also provided are methods for screening for substances which modulate dynein expression levels and the methods of using active agents identified by the screening protocol in the treatment of skin. | 07-05-2012 |
| 20120328546 | Paxillin Stimulating Compositions and Cosmetic Uses Thereof - Cosmetic compositions comprising one or more paxillin stimulators and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The paxillin stimulators and combinations thereof are believed to have modulatory activity against at least one biochemical pathway implicated in skin aging. | 12-27-2012 |
| 20130149268 | Maesa Japonica Extracts and Methods of Use - Methods of using extracts of | 06-13-2013 |
| 20130149397 | Modulation of Thymosin Beta-4 in Skin - Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents, other than a retinoid, that stimulate thymosin beta-4 expression in the skin. Also provided are methods for screening for substances which stimulate thymosin beta-4 expression levels and the methods of using active agents identified by the screening protocol in the treatment of skin. | 06-13-2013 |
| 20140154343 | Modulation of Thymosin Beta-4 in Skin - Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents, other than a retinoid, that stimulate thymosin beta-4 expression in the skin. Also provided are methods for screening for substances which stimulate thymosin beta-4 expression levels and the methods of using active agents identified by the screening protocol in the treatment of skin. | 06-05-2014 |
| 20140161909 | Medemia Nobilis Extracts and Methods of Use - The present invention describes methods for improving the appearance of skin, particularly, treating, ameliorating, preventing, delaying, and/or improving one or more signs of aging, by topically applying compositions comprising an extract of | 06-12-2014 |
| 20140161910 | Serissa Japonica Extracts and Methods of Use - Methods of using extracts of | 06-12-2014 |
| 20140161911 | Hoya Carnosa Extracts and Methods of Use - Methods of using extracts of | 06-12-2014 |
| 20140161917 | Use of Nesprin-2 Expression Modulators and Compositions Thereof - Methods of using nesprin-2 modulators to impart anti-aging benefits to the skin and/or improve skin conditions. | 06-12-2014 |
| 20140193529 | Modulation of Thymosin Beta-4 in Skin - Methods for preventing, ameliorating, or reducing dermatological signs of inflammation are provided which employ active agents, other than a retinoid, that stimulate thymosin beta-4 expression in the skin and inhibit production of pro-inflammatory chemokines and/or cytokines. Also provided are methods for screening for substances which stimulate thymosin beta-4 expression levels and the methods of using active agents identified by the screening protocol in the treatment of skin. | 07-10-2014 |
| 20140301962 | Serissa Japonica Extracts and Methods of Use - Methods of using extracts of | 10-09-2014 |
| 20140329898 | Cosmetic Use of N-Substituted Sulfonyloxybenzylamines and Related Compounds - Cosmetic compositions comprising N-substituted sulfonyloxybenzylamines and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The N-substituted sulfonyloxybenzylamines are believed to have modulatory activity against one or more biochemical pathways implicated in skin aging. | 11-06-2014 |
| 20150202146 | Paxillin Stimulating Compositions and Cosmetic Uses Thereof - Cosmetic compositions comprising one or more paxillin stimulators and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The paxillin stimulators and combinations thereof are believed to have modulatory activity against at least one biochemical pathway implicated in skin aging. | 07-23-2015 |
| 20150283063 | Modulation of Thymosin Beta-4 in Skin - Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents, other than a retinoid, that stimulate thymosin beta-4 expression in the skin. Also provided are methods for screening for substances which stimulate thymosin beta-4 expression levels and the methods of using active agents identified by the screening protocol in the treatment of skin. | 10-08-2015 |
| 20150290118 | Hoya Carnosa Extracts and Methods of Use - Methods of using extracts of | 10-15-2015 |
| Patent application number | Description | Published |
|---|
| 20100251700 | HC-SCR System for Lean Burn Engines - Systems and methods for abating NOx emission in an exhaust stream are provided. Systems comprising hydrocarbon conversion over a partial oxidation catalyst in a slip stream and a hydrocarbon selective catalytic reduction catalyst are described. The emissions treatment system is advantageously used for the treatment of exhaust streams from lean burn engines including diesel engines, lean burn gasoline engines and locomotive engines. | 10-07-2010 |
| 20110173950 | Emissions Treatment System with Ammonia-Generating and SCR Catalysts - Provided are emissions treatment systems for an exhaust stream having an ammonia-generating component, such as a NOx storage reduction (NSR) catalyst or a lean NOx trap (LNT) catalyst, and an SCR catalyst disposed downstream of the ammonia-generating catalyst. The SCR catalyst can be a molecular sieve having the CHA crystal structure, for example SSZ-13 or SAPO-34, which can be ion-exchanged with copper. The LNT can be layered, having an undercoat washcoat layer comprising a support material, at least one precious metal, and at least one NOx sorbent selected from the group consisting of alkaline earth elements, rare earth elements, and combinations thereof and a top washcoat layer comprising a support material, at least one precious metal, and ceria in particulate form, the top washcoat layer being substantially free of alkaline earth components. The emissions treatment system is advantageously used for the treatment of exhaust streams from diesel engines and lean burn gasoline engines. | 07-21-2011 |
| 20130336864 | Composites Of Mixed Metal Oxides For Oxygen Storage - Provided are composites of mixed metal oxides comprising: a ceria-zirconia-alumina composite, wherein the alumina is present in an amount in the range of 1 to less than 30% by weight of the composite and the mixed metal oxide composite has a ceria reducibility of at least 50% after 12 hours of hydrothermal aging at 1050° C. In preparation thereof, a ceria-zirconia solid solution can optionally further comprise at least one rare earth oxide other than ceria and the alumina may be formed by using a colloidal alumina precursor. Methods of making and using these composites are also provided. | 12-19-2013 |
| 20140047819 | Emissions Treatment System with Ammonia-Generating and SCR Catalysts - Provided are emissions treatment systems for an exhaust stream having an ammonia-generating component, such as a NOx storage reduction (NSR) catalyst or a lean NOx trap (LNT) catalyst, and an SCR catalyst disposed downstream of the ammonia-generating catalyst. The SCR catalyst can be a molecular sieve having the CHA crystal structure, for example SSZ-13 or SAPO-34, which can be ion-exchanged with copper. The LNT can be layered, having an undercoat washcoat layer comprising a support material, at least one precious metal, and at least one NOx sorbent selected from the group consisting of alkaline earth elements, rare earth elements, and combinations thereof and a top washcoat layer comprising a support material, at least one precious metal, and ceria in particulate form, the top washcoat layer being substantially free of alkaline earth components. The emissions treatment system is advantageously used for the treatment of exhaust streams from diesel engines and lean burn gasoline engines. | 02-20-2014 |
| 20140248200 | Emissions Treatment System with Ammonia-Generating and SCR Catalysts - Provided are emissions treatment systems for an exhaust stream having an ammonia-generating component, such as a NOx storage reduction (NSR) catalyst or a lean NOx trap (LNT) catalyst, and an SCR catalyst disposed downstream of the ammonia-generating catalyst. The SCR catalyst can be a molecular sieve having the CHA crystal structure, for example SSZ-13 or SAPO-34, which can be ion-exchanged with copper. The LNT can be layered, having an undercoat washcoat layer comprising a support material, at least one precious metal, and at least one NOx sorbent selected from the group consisting of alkaline earth elements, rare earth elements, and combinations thereof and a top washcoat layer comprising a support material, at least one precious metal, and ceria in particulate form, the top washcoat layer being substantially free of alkaline earth components. The emissions treatment system is advantageously used for the treatment of exhaust streams from diesel engines and lean burn gasoline engines. | 09-04-2014 |
| 20140369912 | Integrated Supports for Emission Control Catalysts - Provided is a composite of mixed metal oxides comprising by weight of the composite: alumina in an amount in the range of 1 to 50%; ceria in an amount in the range of 1 to 50% zirconia in an amount in the range of 10 to 70%; and one or more oxides of Group II elements in an amount in the range of 1 to 10%; optionally, one or more oxides Group III elements in an amount in the range of 0 to 20% is present. The mixed metal oxides may be effective integrated supports for precious metals used in emissions catalysts where a single component is an integration of alumina, ceria, zirconia, Group III metal oxides (dopants, e.g., La | 12-18-2014 |
| 20150139874 | Lean NOx Trap Diesel Oxidation Catalyst With Hydrocarbon Storage Function - The present invention is directed to a lean NOx trap diesel oxidation catalyst for the treatment of exhaust gas emissions, such as the oxidation of unburned hydrocarbons (HC), and carbon monoxide (CO) and the trapping and reduction of nitrogen oxides (NOx). Catalytic composites can comprise a catalytic material on a carrier, the catalytic material comprising a first NOx trap layer that comprises a NOx sorbent and one or more precious metal components located on the carrier and a second NOx trap layer containing hydrocarbon trapping functionality located over the first NOx trap layer that comprises a NOx sorbent, one or more precious metal components, and a zeolite, for example a beta zeolite, wherein the zeolite is substantially free of framework aluminum. Such zeolites are characterized by high crystallinity and/or by being substantially free of framework aluminum to minimize surface acidity. | 05-21-2015 |
| 20150174564 | PT-PD Diesel Oxidation Catalyst With CO/HC Light-Off And HC Storage Function - A diesel oxidation catalyst for the treatment of exhaust gas emissions, such as the oxidation of unburned hydrocarbons (HC), and carbon monoxide (CO) and the reduction of nitrogen oxides (NOx) is described. More particularly, the present invention is directed to a washcoat composition comprising high silica to alumina zeolite and platinum and palladium such that the zeolite minimizes negative interactions of these platinum group metals with the zeolite. | 06-25-2015 |
| Patent application number | Description | Published |
|---|
| 20130197881 | Method and System for Patient Specific Planning of Cardiac Therapies on Preoperative Clinical Data and Medical Images - A method and system for patient-specific planning of cardiac therapy, such as cardiac resynchronization therapy (CRT), based on preoperative clinical data and medical images, such as ECG data, magnetic resonance imaging (MRI) data, and ultrasound data, is disclosed. A patient-specific anatomical model of the left and right ventricles is generated from medical image data of a patient. A patient-specific computational heart model, which comprises cardiac electrophysiology, biomechanics and hemodynamics, is generated based on the patient-specific anatomical model of the left and right ventricles and clinical data. Simulations of cardiac therapies, such as CRT at one or more anatomical locations are performed using the patient-specific computational heart model. Changes in clinical cardiac parameters are then computed from the patient-specific model, constituting predictors of therapy outcome useful for therapy planning and optimization. | 08-01-2013 |
| 20130197884 | Method and System for Advanced Measurements Computation and Therapy Planning from Medical Data and Images Using a Multi-Physics Fluid-Solid Heart Model - Method and system for computation of advanced heart measurements from medical images and data; and therapy planning using a patient-specific multi-physics fluid-solid heart model is disclosed. A patient-specific anatomical model of the left and right ventricles is generated from medical image patient data. A patient-specific computational heart model is generated based on the patient-specific anatomical model of the left and right ventricles and patient-specific clinical data. The computational model includes biomechanics, electrophysiology and hemodynamics. To generate the patient-specific computational heart model, initial patient-specific parameters of an electrophysiology model, initial patient-specific parameters of a biomechanics model, and initial patient-specific computational fluid dynamics (CFD) boundary conditions are marginally estimated. A coupled fluid-structure interaction (FSI) simulation is performed using the initial patient-specific parameters, and the initial patient-specific parameters are refined based on the coupled FSI simulation. The estimated model parameters then constitute new advanced measurements that can be used for decision making. | 08-01-2013 |
| 20130246034 | Method and System for Non-Invasive Functional Assessment of Coronary Artery Stenosis - A method and system for non-invasive assessment of coronary artery stenosis is disclosed. Patient-specific anatomical measurements of the coronary arteries are extracted from medical image data of a patient acquired during rest state. Patient-specific rest state boundary conditions of a model of coronary circulation representing the coronary arteries are calculated based on the patient-specific anatomical measurements and non-invasive clinical measurements of the patient at rest. Patient-specific rest state boundary conditions of the model of coronary circulation representing the coronary arteries are calculated based on the patient-specific anatomical measurements and non-invasive clinical measurements of the patient at rest. Hyperemic blood flow and pressure across at least one stenosis region of the coronary arteries are simulated using the model of coronary circulation and the patient-specific hyperemic boundary conditions. Fractional flow reserve (FFR) is calculated for the at least one stenosis region based on the simulated hyperemic blood flow and pressure. | 09-19-2013 |
| 20140012558 | SYSTEM AND METHODS FOR INTEGRATED AND PREDICTIVE ANALYSIS OF MOLECULAR, IMAGING, AND CLINICAL DATA FOR PATIENT-SPECIFIC MANAGEMENT OF DISEASES - A system operating in a plurality of modes to provide an integrated analysis of molecular data, imaging data, and clinical data associated with a patient includes a multi-scale model, a molecular model, and a linking component. The multi-scale model is configured to generate one or more estimated multi-scale parameters based on the clinical data and the imaging data when the system operates in a first mode, and generate a model of organ functionality based on one or more inferred multi-scale parameters when the system operates in a second mode. The molecular model is configured to generate one or more first molecular findings based on a molecular network analysis of the molecular data, wherein the molecular model is constrained by the estimated parameters when the system operates in the first mode. The linking component, which is operably coupled to the multi-scale model and the molecular model, is configured to transfer the estimated multi-scale parameters from the multi-scale model to the molecular model when the system operates in the first mode, and generate, using a machine learning process, the inferred multi-scale parameters based on the molecular findings when the system operates in the second mode. | 01-09-2014 |
| 20140024932 | Computation of Hemodynamic Quantities From Angiographic Data - Methods for computing hemodynamic quantities include: (a) acquiring angiography data from a patient; (b) calculating a flow and/or calculating a change in pressure in a blood vessel of the patient based on the angiography data; and (c) computing the hemodynamic quantity based on the flow and/or the change in pressure. Systems for computing hemodynamic quantities and computer readable storage media are described. | 01-23-2014 |
| 20140058715 | Method and System for Non-Invasive Functional Assessment of Coronary Artery Stenosis - A method and system for non-invasive assessment of coronary artery stenosis is disclosed. Patient-specific anatomical measurements of the coronary arteries are extracted from medical image data of a patient acquired during rest state. Patient-specific rest state boundary conditions of a model of coronary circulation representing the coronary arteries are calculated based on the patient-specific anatomical measurements and non-invasive clinical measurements of the patient at rest. Patient-specific rest state boundary conditions of the model of coronary circulation representing the coronary arteries are calculated based on the patient-specific anatomical measurements and non-invasive clinical measurements of the patient at rest. Hyperemic blood flow and pressure across at least one stenosis region of the coronary arteries are simulated using the model of coronary circulation and the patient-specific hyperemic boundary conditions. Fractional flow reserve (FFR) is calculated for the at least one stenosis region based on the simulated hyperemic blood flow and pressure. | 02-27-2014 |
| Patent application number | Description | Published |
|---|
| 20150112182 | Method and System for Machine Learning Based Assessment of Fractional Flow Reserve - A method and system for determining fractional flow reserve (FFR) for a coronary artery stenosis of a patient is disclosed. In one embodiment, medical image data of the patient including the stenosis is received, a set of features for the stenosis is extracted from the medical image data of the patient, and an FFR value for the stenosis is determined based on the extracted set of features using a trained machine-learning based mapping. In another embodiment, a medical image of the patient including the stenosis of interest is received, image patches corresponding to the stenosis of interest and a coronary tree of the patient are detected, an FFR value for the stenosis of interest is determined using a trained deep neural network regressor applied directly to the detected image patches. | 04-23-2015 |
| 20150235360 | Sparse Appearance Learning-based Segmentation - The coronary sinus or other vessel is segmented by finding a centerline and then using the centerline to locate the boundary of the vessel. For finding the centerline, a refinement process uses multi-scale sparse appearance learning. For locating the boundary, the lumen is segmented as a graph cut problem. | 08-20-2015 |
| 20150238148 | METHOD AND SYSTEM FOR ANATOMICAL OBJECT DETECTION USING MARGINAL SPACE DEEP NEURAL NETWORKS - A method and system for anatomical object detection using marginal space deep neural networks is disclosed. The pose parameter space for an anatomical object is divided into a series of marginal search spaces with increasing dimensionality. A respective deep neural network is trained for each of the marginal search spaces, resulting in a series of trained deep neural networks. Each of the trained deep neural networks can evaluate hypotheses in a current parameter space using discriminative classification or a regression function. An anatomical object is detected in a medical image by sequentially applying the series of trained deep neural networks to the medical image. | 08-27-2015 |
| 20150359601 | Method and System for Improved Hemodynamic Computation in Coronary Arteries - Systems and methods for non-invasive assessment of an arterial stenosis, comprising include segmenting a plurality of mesh candidates for an anatomical model of an artery including a stenosis region of a patient from medical imaging data. A hemodynamic index for the stenosis region is computed in each of the plurality of mesh candidates. It is determined whether a variation among values of the hemodynamic index for the stenosis region in each of the plurality of mesh candidates is significant with respect to a threshold associated with a clinical decision regarding the stenosis region. | 12-17-2015 |
| Patent application number | Description | Published |
|---|
| 20110007800 | METHODS AND APPARATUS FOR ILLUMINATION COMPENSATION OF INTRA-PREDICTED VIDEO - There are provided methods and apparatus for illumination compensation of intra-predicted video. An apparatus includes an encoder for encoding a picture using non-local intra prediction. The encoder includes an illumination compensation processing unit for applying illumination compensation to predicted data obtained from the non-local intra prediction. | 01-13-2011 |
| 20110103464 | Methods and Apparatus for Locally Adaptive Filtering for Motion Compensation Interpolation and Reference Picture Filtering - Methods and apparatus are provided for locally adaptive filtering for motion compensation interpolation and reference picture filtering. An apparatus includes an encoder for encoding picture data. The encoder includes at least one locally adaptive filter for performing locally adaptive filtering for at least one of reference picture filtering and interpolation filtering with respect to the picture data. | 05-05-2011 |
| 20110158320 | METHODS AND APPARATUS FOR PREDICTION REFINEMENT USING IMPLICIT MOTION PREDICTIONS - Methods and apparatus are provided for prediction refinement using implicit motion prediction. An apparatus includes an encoder for encoding an image block using explicit motion prediction to generate a coarse prediction for the image block and using implicit motion prediction to refine the coarse prediction. | 06-30-2011 |
| 20110222597 | METHOD AND APPARATUS FOR SPARSITY-BASED DE-ARTIFACT FILTERING FOR VIDEO ENCODING AND DECODING - Methods and apparatus are provided for sparsity-based de-artifact filtering for video encoding and decoding. An apparatus includes an encoder ( | 09-15-2011 |
| 20110261882 | METHODS AND APPARATUS FOR TEMPLATE MATCHING PREDICTION (TMP) IN VIDEO ENCODING AND DECODING - Methods and apparatus are provided for template matching prediction in video encoding and decoding. An apparatus includes an encoder for encoding a target block in a picture by determining at least one predictor for the target block and respectively utilizing the at least one predictor as a template to search for at least one additional predictor for the target block. | 10-27-2011 |
| 20110268183 | METHOD AND APPARATUS FOR TRANSFORM SELECTION IN VIDEO ENCODING AND DECODING - There are provided methods and apparatus for transform selection in video coding. An apparatus includes a video encoder for encoding at least a block in a picture by selecting a transform to apply to a residue of the block from a set of two or more available transforms. The transform is selected based on at least one of an inter prediction mode used to predict at least one reference for the block, one or more values corresponding to a motion vector, a value of a residue of one or more previously encoded blocks, a value of prediction data for the block, one or more transform selections of one or more neighboring reconstructed blocks, and a quantization step applied to transform coefficients for the residue of the block. | 11-03-2011 |
| 20110274164 | METHODS AND APPARATUS FOR TRANSFORM SELECTION IN VIDEO ENCODING AND DECODING - There are provided methods and apparatus for transform selection in video coding. An apparatus includes a video encoder for encoding at least a block in a picture by selecting a transform to apply to a residue of the block from a set of two or more available transforms. The transform is selected based on at least one of an inter prediction mode used to predict at least one reference for the block, one or more values corresponding to a motion vector, a value of a residue of one or more previously encoded blocks, a value of prediction data for the block, one or more transform selections of one or more neighboring reconstructed blocks, and a quantization step applied to transform coefficients for the residue of the block. | 11-10-2011 |
| 20110286513 | METHODS AND APPARATUS FOR ADAPTIVE MODE VIDEO ENCODING AND DECODING - There are provided methods and apparatus for adaptive mode video encoding and decoding. An apparatus includes an encoder for encoding adapted mode mapping information for a mapping between values of a mode index and modes available to encode at least a portion of a picture in a sequence of pictures. The adapted mode mapping information is adapted based on one or more actual parameters of the sequence. | 11-24-2011 |
| 20110286520 | METHODS AND APPARATUS FOR IMPLICIT AND SEMI-IMPLICIT INTRA MODE SIGNALING FOR VIDEO AND DECODERS - Methods and apparatus are provided for implicit and semi-implicit intra mode signaling for video encoders and decoders. An apparatus includes an encoder for encoding picture data for at least a portion of a picture. The encoder derives an intra mode to apply to the portion from neighboring template data and abstains from explicitly signaling the intra mode for the portion. The neighboring template data corresponds to a neighboring template formed from neighboring pixels with respect to the portion. | 11-24-2011 |
| 20110293002 | METHODS AND APPARATUS FOR TRANSFORM SELECTION IN VIDEO ENCODING AND DECODING - There are provided methods and apparatus for transform selection in video coding. An apparatus includes a video encoder for encoding at least a block in a picture by selecting a transform to apply to a residue of the block from a set of two or more available transforms. The transform is selected based on at least one of an inter prediction mode used to predict at least one reference for the block, one or more values corresponding to a motion vector, a value of a residue of one or more previously encoded blocks, a value of prediction data for the block, one or more transform selections of one or more neighboring reconstructed blocks, and a quantization step applied to transform coefficients for the residue of the block. | 12-01-2011 |
| 20120030219 | METHODS AND APPARATUS FOR FILTER PARAMETER DETERMINATION AND SELECTION RESPONSIVE TO VARRIABLE TRANSFROMS IN SPARSITY BASED DE-ARTIFACT FILTERING - There are provided method and apparatus for filter parameter determination and selection responsive to variable transforms in sparsity-based de-artifact filtering. An apparatus includes an encoder for encoding picture data for at least a portion of a picture. The encoder includes a sparsity-based de-artifact filter for performing sparsity-based de-artifact filtering on the portion. One or more filter parameters for the sparsity-based de-artifact filtering are determined and selected responsive to variable transforms. | 02-02-2012 |
| 20120106627 | METHODS AND APPARATUS FOR VIDEO ENCODING AND DECODING USING ADAPTIVE GEOMETRIC PARTITIONING - Methods and apparatus are provided for video encoding and decoding using adaptive geometric partitioning. An apparatus includes an encoder for encoding picture data for a region in a picture using adaptive geometric partitioning, wherein a subset of geometric partitions used to code the picture data for the region is determined responsive to at least one of a distance and an angle. The distance is measured from a defined point within the region to a partition boundary. The angle is measured with respect to at least a line extending from the defined point within the region to the partition boundary. | 05-03-2012 |
| 20120177129 | METHODS AND APPARATUS FOR ADAPTIVE PROBABILITY UPDATE FOR NON-CODED SYNTAX - There is provided an apparatus. The apparatus includes an encoder ( | 07-12-2012 |
| 20130044814 | METHODS AND APPARATUS FOR ADAPTIVE INTERPOLATIVE INTRA BLOCK ENCODING AND DECODING - Methods and apparatus are provided for adaptive interpolative intra block encoding and decoding. An apparatus includes a video encoder for encoding at least an intra block in a picture by dividing the intra block into at least a first partition and a second partition, and generating predictions of pixels in the second partition by adaptively interpolating reconstructed pixels from the first partition. | 02-21-2013 |
| 20130058413 | METHODS AND APPARATUS FOR UNI-PREDICTION OF SELF-DERIVATION OF MOTION ESTIMATION - Methods and apparatus are provided for uni-prediction of self-derivation of motion estimation. An apparatus includes a video encoder for encoding at least a portion of a picture. The video encoder includes a self derivation motion estimator for performing self derivation motion estimation for the portion. The self derivation motion estimation is used for selectively performing uni-prediction or bi-prediction for the portion based on one or more criterion. | 03-07-2013 |
